Search clinical trials for: Tocilizumab (interleukin 6 inhibitor)

Total 1231 results

Tanta University

Completed

IL- 6 Gene (174G/C) Single Nucleotide Polymorphism as an Indicator of COVID-19 Severity in Egyptian Patients

Covid19

Egypt
King Faisal Specialist Hospital & Research Center
Society of Critical Care Medicine

Unknown

Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19

Critical Illness | Corona Virus Infection | Cytokine Release Syndrome

Saudi Arabia
Sohag University

Not yet recruiting

THE VALUE OF INTERLEUKIN 6 AS A DIAGNOSTIC MARKER IN NEONATAL SEPSIS

NEONATAL SEPSIS

Egypt
Beni-Suef University

Completed

Serum Interleukin 6 in Chronic Obstructive Pulmonary Disease

Chronic Obstr Lung Disease

Egypt
Lisa Barrett
Nova Scotia Health Authority; Dalhousie University

Active, not recruiting

Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients

COVID-19

Canada
Cengiz Gokcek Women's and Children's Hospital

Completed

Analyses of Interleukin-6, Presepsin and Pentraxin-3 in the Diagnosis and Severity of Late-onset Preeclampsia (Presepsin&PE)

Preeclampsia

Turkey
Xiaoming Gong

Completed

Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis

Rheumatoid Arthritis

China
Ministry of Health, Saudi Arabia

Not yet recruiting

Measurment of Interleuukin-6 at Exhaled Breath Condensate of Covid-19 Patients and Post Covid-19 Patients With Lung Fibrosis Randomized Controlled Study

COVID-19 | Inflammatory Response | Immunological Abnormality
University Hospital Ostrava

Completed

Acute Kidney Injury in Severe Trauma

Acute Kidney Injury

Czechia
Ministry of Health, Saudi Arabia

Enrolling by invitation

SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study

Diabetes Mellitus, Type 2 | Cancer | Interleukin 6 | SGLT2 Inhibitors

Saudi Arabia
University Hospital, Brest

Completed

Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica (TENOR-IMMUNO)

Polymyalgia Rheumatica

France
H. Lee Moffitt Cancer Center and Research Institute
EUSA Pharma, Inc.

Recruiting

Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)

Large Granular Lymphocyte Leukemia

United States
FARAH AFZAL

Completed

Role of Interleukin-6 and Procalcitonin as Novel Inflammatory Biomarkers in Evaluating COVID 19 Disease Severity - an Experience at CMH Quetta

Covid19 Positive Patients

Pakistan
Hellenic Institute for the Study of Sepsis

Completed

Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction (ESCAPE)

Virus Diseases | COVID-19 | Corona Virus Infection | Macrophage Activation Syndrome

Greece
Assistance Publique - Hôpitaux de Paris

Unknown

Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis (RUBI)

Uveitis | Biotherapy

France
Biocad

Completed

First-in-human Study of Safety, Pharmacokinetics and Pharmacodynamics of Various Doses of BCD-089 in Healthy Subjects

Healthy

Russian Federation
Beijing VDJBio Co., LTD.

Recruiting

A Study of Anti-IL-6R mAb Injection in Patients With iMCD

Idiopathic Multicentric Castleman's Disease

China
Assiut University

Recruiting

Beta Endorphins,Interleukin 1 and Interleukin 38 in Covid Patients Associated With Neuropsychological Manifestations.

Covid Patients

Egypt
Assiut University

Completed

Adiponectin, IL-6 and hsC-RP in Relation to Carotid Intima-media Thickness in B-thalassemia Patients

Thalassemia

Egypt
National Cancer Institute (NCI)

Terminated

Tocilizumab for Patients With Cancer and COVID-19 Disease

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Pneumonia | Symptomatic COVID-19 Infection Laboratory-Confirmed | Severe Acute Respiratory Distress Syndrome | Pneumonitis

United States
Bozok University

Completed

Effect of Preoperative Anxiety on Fetus in Pregnant Women

Preoperative Anxiety | Cytokines

Turkey
Institut für Klinische Krebsforschung IKF GmbH...

Recruiting

Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast Cancer

Breast Cancer

Germany
Assistance Publique Hopitaux De Marseille

Unknown

A Trial Using ANAKINRA, TOCILIZUMAB Alone or in Association With RUXOLITINIB in Severe Stage 2b and 3 of COVID19-associated Disease (INFLAMMACOV)

Covid19

France
University of California, San Diego
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Pilot Study of Atorvastatin and Anakinra in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease

Kawasaki Disease

United States
Centre Chirurgical Marie Lannelongue

Unknown

Evaluation of the Effectiveness of Non-invasive Ventilation on the Reperfusion Pulmonary Edema Post Pulmonary Artery Angioplasty in the Post Embolic Pulmonary Hypertension (OPR_VNI)

Reperfusion Pulmonary Edema

France
Research Institute of Epidemiology, Microbiology...

Recruiting

Impact of A. Lumbricoides on Pulmonary Aspergillosis Development

Chronic Pulmonary Aspergillosis | COPD Exacerbation Acute | Ascaris Lumbricoides Infection

Uzbekistan
University Hospital, Ghent
Belgium Health Care Knowledge Centre

Completed

Treatment of COVID-19 Patients With Anti-interleukin Drugs (COV-AID)

COVID-19

Belgium
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Terminated

Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Emory University
National Cancer Institute (NCI)

Withdrawn

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Coronary Artery Disease | Diabetes Mellitus | Chronic Obstructive Pulmonary Disease | Cerebrovascular Accident | Chronic Renal Failure | Malignant Neoplasm | SARS Coronavirus 2 Infection

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Tocilizumab for Chronic Graft-versus-Host Disease Treatment

Graft Versus Host Disease

United States
Medical University of Lodz

Completed

Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis

Myocardial Infarction | Ischemic Stroke | Endocarditis | Patent Foramen Ovale | Embolic Stroke of Undetermined Source | Atrial Fibrillation and Flutter | Cardiac Tumor
G1 Therapeutics, Inc.

Recruiting

Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

Extensive-stage Small-cell Lung Cancer

Spain, Greece, Turkey, Poland, Georgia, Austria, Belgium, Bulgaria, Germany, Hungary
Emory University
National Cancer Institute (NCI)

Recruiting

Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma

Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Henan Cancer Hospital

Recruiting

A Trail of CDK4 / 6 Inhibitor and MEK Inhibitor in the Treatment of Metastatic Digestive System Tumors

Digestive System Tumors

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Anal Cancer | Gallbladder Cancer

United States
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

Asthma

United States
Indiana University School of Medicine
National Cancer Institute (NCI)

Completed

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Lymphoma | Kidney Cancer | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Terminated

Interleukin-12 Gene Therapy in Treating Patients With Skin Metastases

Metastatic Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Interleukin-12 in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Epidemic Kaposi's Sarcoma | Recurrent Kaposi's Sarcoma

United States
National Cancer Institute (NCI)

Completed

Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial Cancer

United States
G1 Therapeutics, Inc.

Completed

First-in-Human Safety, PK, and Food Effect Study of Single Ascending Doses of G1T38 in Healthy Volunteers

Healthy Volunteers

Netherlands
RenJi Hospital

Recruiting

CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer

Breast Cancer

China
G1 Therapeutics, Inc.

Completed

Safety, Pharmacokinetic and Pharmacodynamic Study of the CDK 4/6 Inhibitor G1T28-1

Healthy Volunteers

Netherlands
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix

Cervical Cancer

United States
Avidia

Unknown

Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease

Crohn's Disease

Australia
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Interleukin-12 in Treating Patients With Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
National Cancer Institute (NCI)

Terminated

Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma

Recurrent Neuroblastoma

United States
Karolinska University Hospital
Karolinska Institutet

Recruiting

A Study in Patients With COVID-19 and Respiratory Distress Not Requiring Mechanical Ventilation, to Compare Standard-of-care With Anakinra and Tocilizumab Treatment The Immunomodulation-CoV Assessment (ImmCoVA) Study

Covid-19

Sweden

Search clinical trials for: Tocilizumab (interleukin 6 inhibitor)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations